Filaggrin Mutation Status and Prevention of Atopic Dermatitis with Maternal Probiotic Supplementation
Acta Dermato-Venereologica · 2024
DOI: 10.2340/actadv.v104.24360 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Acta Dermato-Venereologica, 2024. Verfasst von Dinastry Pramadita Zakiudin und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Public Health and Nursing, NTNU - Norwegian University of Science and Technology, Trondheim, Norway; Clinic for Laboratory Medicine, St…. Hauptthemen laut MEDLINE: Dermatitis, Atopic, Filaggrin Proteins, Intermediate Filament Proteins, Mutation. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 71 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Helse Midt-Norge.
Abstract (Originalsprache)
The World Allergy Organization recommends probiotics in the prevention of atopic dermatitis in high-risk populations. Mutations in the filaggrin gene (FLG) result in an increased risk of atopic dermatitis through disruption of the skin keratin layer. This exploratory study investigated whether the preventive effect of maternal probiotics was evident in children with and without FLG mutations. DNA was collected from children (n = 228) from the Probiotic in the Prevention of Allergy among Children in Trondheim (ProPACT) study. Samples were analysed for 3 common FLG mutations (R501X, R2447X, and 2282del4). Overall, 7% of children had heterozygous FLG mutations; each child had only one of the 3 mutations. Mutation status had no association with atopic dermatitis (RR = 1.1; 95% CI 0.5 to 2.3). The risk ratio (RR) for having atopic dermatitis following maternal probiotics was 0.6 (95% CI 0.4 to 0.9) and RR was similar if the child expressed an FLG mutation (RR = 0.6; 95% CI 0.1 to 4.1) or wildtype FLG (RR = 0.6; 95% CI 0.4 to 0.9). The preventive effect of probiotics for atopic dermatitis was also evident in children without FLG mutation. Larger confirmatory studies are needed.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Public Health and Nursing, NTNU - Norwegian University of Science and Technology, Trondheim, Norway; Clinic for Laboratory Medicine, St Olavs Hospital, Trondheim, Norway. dinastry.p.zakiudin@ntnu.no.
- Department of Dermatology and Venereology, Bispebjerg Hospital, University of Copenhagen, Copenhagen, Denmark.
- Department of Clinical Medicine, University Hospital of Copenhagen Gentofte, Hellerup, Denmark; Department of Dermatology and Allergy, University Hospital of Copenhagen Gentofte, Hellerup, Denmark.
- Department of Clinical and Molecular Medicine, NTNU - Norwegian University of Science and Technology, Trondheim, Norway; St. Olavs Hospital, Trondheim University Hospital, Department of Immunology and Transfusion Medici…
- Department of Public Health and Nursing, NTNU - Norwegian University of Science and Technology, Trondheim, Norway.
Förderung
- Helse Midt-Norge
Zitieren
APA
Zakiudin, D. P., Thyssen, J. P., Zachariae, C., Videm, V., Øien, T., & Simpson, M. R. (2024). Filaggrin Mutation Status and Prevention of Atopic Dermatitis with Maternal Probiotic Supplementation. Acta Dermato-Venereologica. https://doi.org/10.2340/actadv.v104.24360
Vancouver
Zakiudin DP, Thyssen JP, Zachariae C, Videm V, Øien T, Simpson MR. Filaggrin Mutation Status and Prevention of Atopic Dermatitis with Maternal Probiotic Supplementation. Acta Dermato-Venereologica. 2024. doi:10.2340/actadv.v104.24360
BibTeX
@article{Zakiudin2024,
author = {Zakiudin, Dinastry Pramadita and Thyssen, Jacob P and Zachariae, Claus and Videm, Vibeke and Øien, Torbjørn and Simpson, Melanie Rae},
title = {Filaggrin Mutation Status and Prevention of Atopic Dermatitis with Maternal Probiotic Supplementation},
journal = {Acta Dermato-Venereologica},
year = {2024},
doi = {10.2340/actadv.v104.24360}
}
EUVIMED